T1	Participants 71 138	patients having coronary stent implantation treated with prasugrel.
T2	Participants 211 296	patients with acute coronary syndromes undergoing percutaneous coronary intervention.
T3	Participants 490 619	total 298 consecutive patients 68 ± 10 years old (31% >75 years old) underwent stent implantation and received prasugrel therapy
T4	Participants 1036 1037	.
T5	Participants 1038 1089	Patients ≥75 years old and with body weight ≤60
